Page 6 - Read Online

Hepatoma Research

C O NT E NT S

Editorial

1 Combining locoregional and systemic therapies in liver cancer: from strategy to survival 1
Bin-Yan Zhong

Original Article

2 A baseline-lymphocyte-subset nomogram for predicting severe immune-related adverse events in
hepatocellular carcinoma patients receiving TACE plus immunotherapy 5
Zeyu Yu, Ran You, Chendong Wang, Bin Leng, Lingfeng Diao, Qingyu Xu, Guowen Yin

Review

3 Thermal ablation therapy for hepatocellular carcinoma: recurrence mechanisms and intervention strategies 17
Xuehan Li, Shun Li, Yingjing Li, Ge Yuan, Yan Zhang, Jiaqi Shi, Caiqi Liu, Xianjun Li, Tongsen Zheng

4 Yttrium-90 combination therapies in hepatocellular carcinoma: current evidence and future directions 30
Bailey Hall, Zachary Ohs, Mario Dervishi, Alex Stevens, Christopher Sutter, Jon Davidson

5 Synergistic era: practice and reflection on TACE combined with systemic therapy in hepatocellular
carcinoma 45
Chenghui Li, Li Chen, Hangfei Bao, Yuchen Wang, Jinhe Guo, Guangyu Zhu

6 Relationship between transarterial chemoembolization treatment frequency and prognosis in hepatocellular
carcinoma patients 60
Yu-Yan Ma, Li Chen, Cheng-Hui Li, Yue-Yong Li, Guo-Jun Li, Hai-Dong Zhu

Hepatoma Research III